#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell type acute leukaemia Myelofibrosis Anti-myelin-associated glycoprotein antibodies positive Atopic keratoconjunctivitis Cutaneous T-cell lymphoma refractory Bile acid synthesis disorder Ureteric cancer Myelin oligodendrocyte glycoprotein antibody-associated disease Ocular lymphoma Shprintzen-Goldberg syndrome Lennox-Gastaut syndrome Oesophageal adenocarcinoma stage II Medullary thyroid cancer Rett syndrome Malignant fibrous histiocytoma More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Trials in Disease Biotinidase deficiency – Life with Disease Metachromatic leukodystrophy – Trials in Disease Glomerulonephritis rapidly progressive – Treatment Cytokine release syndrome – Life with Disease Lymphangiosarcoma – Diagnostics Behcet’s syndrome – Basic Information Ehlers-Danlos syndrome – Treatment Splenic marginal zone lymphoma – Basic Information Cytokine release syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Psilocybine Valsartan IMEROPRUBART Sodium Fluoride (18F) Paeonol Enasidenib Mesilate Morf-057 Cetuximab CILOSTAZOL SULBACTAM SODIUM Magnesium Citrate Gemcitabine Hydrochloride Pazopanib Ro7247669 Ublituximab Paraffin White Soft Valproate Semisodium [99MTC]PSMA I&S ROPINIROLE Nicotinamide More therapies…

    Learn about Your Condition

    Diminished ovarian reserve Anaemia Rectal cancer stage II Peritonitis Impaired gastric emptying Pancreatic failure Haemofiltration Adenosquamous cell lung cancer Oral herpes Craniopharyngioma Asymptomatic HIV infection Post-traumatic headache Leiomyosarcoma recurrent Stress urinary incontinence Hypochondroplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Frisius

Frisius

Henri Dunantweg 2, Heerenveen, 8934 AD, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polymyalgia rheumatica
    Investigated Drugs:
    • Sarilumab
    • Prednisone
    Austria Belgium Czechia France Germany Greece +3

  • Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Gimeracil
    • Oteracil
    • Tegafur
    The Netherlands

  • A study of tirofiban and adenosine to treat small blood vessel damage in patients with ST-elevation myocardial infarction

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Adenosine
    France The Netherlands Spain

  • A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

    Recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    • Arteriosclerosis
    Austria Belgium Bulgaria Czechia Estonia France +10

  • A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    Austria Belgium Denmark Estonia Finland Germany +8

  • Testing a Drug Combination with Fluorouracil, Irinotecan, Oxaliplatin, and Folinic Acid Plus Radiation Therapy for Patients with Advanced Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • A Study Testing Erector Spinae Plane Block with Ropivacaine versus Placebo for Pain Relief in Adults with Acute Kidney Stone Pain in the Emergency Department

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    The Netherlands

  • A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Salbutamol Sulfate
    • Depemokimab
    Belgium Croatia Denmark France Germany Hungary +8

  • Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation

    Recruiting

    2 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • AP31969 SULFATE
    Bulgaria Denmark Germany Hungary Italy The Netherlands +1

  • Study of drug combination therapy for patients with lymph node-positive esophageal and esophagogastric junction cancer using carboplatin, paclitaxel, fluorouracil, folinic acid, docetaxel and oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    • Oesophageal carcinoma
    Investigated Drugs:
    • Carboplatin
    • Docetaxel
    • Fluorouracil
    The Netherlands
1 2 3 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!